Bizarre Patents
A self defense weapon formed as a memo pad and which is easily held by a person's fingers, therefore making it possible to provide protection from a mugger and also to quickly and easily write a record or a message without failure of missing or forgetting significant information under a stressful situation.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6787529 | Topical composition The present invention relates to a pharmaceutical gel composition for application on skin, said composition comprising at least one vitamin D or vitamin D analogue and at least one corticosteroid as well as a viscosity-increasing excipient. ... | 09/07/2004 |
| 6784169 | MMP inhibitors Novel compounds according to formula I n is 0, 1, 2 or 3; X represents hydroxamic acid (CONHOH), carboxylic acid, phosphonic acid, acetylthiomethyl group or a mercaptomethyl group; R2, R10 and R11 independently re... | 08/31/2004 |
| 6753013 | Pharmaceutical composition A pharmaceutical composition for dermal use, wherein the composition has a first pharmacologically active component A consisting of at least one vitamin D or vitamin D analogue, and a second pharmacologically active component B consisting of at least one corticoster... | 06/22/2004 |
| 6750253 | Aminobenzophenones as inhibitors of il-1β and tnf-α The present invention relates to compounds of the formula wherein R1 independently represents one or more, same or different substituents selected from the group consisting of halogen, hydroxy, mercapto, trifl... | 06/15/2004 |
| 6673783 | Fusidic acid derivatives Novel 17,20-methanofusidic acid derivatives are used in pharmaceutical compositions for the treatment of infections, in particular in topical compositions for the treatment of skin or eye infections.... | 01/06/2004 |
| 6646129 | Cyanoguanidines as cell proliferation inhibitors The present invention relates to hitherto unknown compounds of formula (I) or their tautomeric forms, ##STR1## the attachment to the pyridine ring being in the 3- or 4-position, in which formula R stands for one or more substituents which can be the same ... | 11/11/2003 |
| 6646143 | Vitamin D analogues Compounds of the formula I ##STR1## wherein X represents hydrogen or hydroxy; R1 and R2, which may be the same or different, represent hydrogen, (C1 -C4)alkyl optionally substituted with one hydroxyl group or on... | 11/11/2003 |
| 6624199 | Aminobenzophenones The present invention relates to compounds of formula I ##STR1## wherein R1 represents one or more, similar or different substituents; R2 represents hydrogen, hydroxy, halogen, alkyl, alkoxy, alkylthio, or cyano; R3 repres... | 09/23/2003 |
| 6593319 | Fusidic acid derivatives Novel 17,20-dihydrofusidic acid derivatives are used in pharmaceutical compositions for the treatment of infections, in particular in topical compositions for the treatment of skin or eye infections.... | 07/15/2003 |
| 6573255 | Vitamin D analogues Vitamin D compounds formula I ##STR1## wherein R represents hydrogen, or R represents (C1 -C6)alkyl, phenyl, or (C7 -C9)aralkyl, optionally substituted with one or more groups selected from (C1 -C | 06/03/2003 |
| 6541670 | Aminobenzophenones as inhibitors of IL 1ଲ and TNF- A compound of the general formula I ##STR1## wherein R1 represents a substituent selected from the group consisting of halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1 -C3)alkyl, (C2 -C3)olefin... | 04/01/2003 |
| 6537980 | Vitamin D analogues and their pharmaceutical use The present invention relates to compounds of general formula (I) wherein R1 and R2, which may be the same or different, represent (C1 -C4)alkyl, and R3 represents hydrogen, halogen, (C1 -C... | 03/25/2003 |
| 6525077 | Cyanoguanidine prodrugs A compound of the formula ##STR1## is disclosed, the compound being suited for therapeutical uses. The invention also discloses compositions comprising said compound, methods of treatment involving administering said compound to a patient, and the use ... | 02/25/2003 |
| 6521606 | Matrix metalloproteinase inhibitors A compound of the general formula I ##STR1## wherein Y is O or S; n is 1, 2, 3 or 4; X represents hydroxamic acid, carboxylic acid, phosphonic acid, acetylthiomethyl group or a mercaptomethyl group; R1 is ##STR2## wherein E, when present represents, a bon... | 02/18/2003 |
| 6486137 | Oligosaccharide mixtures having antithrombotic activity A mixture of linear oligosaccharides containing different numbers of repeating sulphated disaccharide units derived from L-iduronic acid (IdoA) and N-acetyl-D-galactosamine (Gal-NAc) and having the following characteristics (a) a molecular weight in the r... | 11/26/2002 |
| 6432962 | Benzophenones as inhibitors of IL-1ଲ and TNF- Heteroaryl aminobenzophenones of general formula I inhibit interleukin-1ଲ and TNF- and may therefore be useful in the therapy of inflammatory diseases and conditions.... | 08/13/2002 |
| 6346541 | Cyanoguanidines as cell proliferation inhibitors ##STR1## The present invention relates to hitherto unknown compounds of formula (I) or their tautomeric forms, the attachment to the pyridine ring being in the 3- or 4-position, in which formula R1 stands for one or more substituents which can ... | 02/12/2002 |
| 6346520 | Cyanoguanidines as cell proliferation inhibitors The present invention relates to hitherto unknown compounds of formula (I) or their tautomeric forms, the attachment to the pyridine ring being in the 3- or 4-position, in which formula R stands for one or more substituents which can be the same or differ... | 02/12/2002 |
| 6310226 | Vitamin D analogues The present invention relates to compounds of formula (I) in which formula X is hydrogen or hydroxy; R1 and R2 which may be the same or different, stand for hydrogen or C1 -C5 hydrocarbyl; or R1 and R... | 10/30/2001 |
| 6303641 | Cyanoamidines as cell proliferation inhibitors Compounds of the following formula are used for inhibiting cell proliferation: ##STR1## wherein R, R1, Q, X are as defined in the specification.... | 10/16/2001 |
| 6277876 | Matrix metalloproteinase inhibitors Compounds of the formula (I) ##STR1## where X is a --CO2 H or --CONHOH group; Y and Z are independently sulphur or oxygen, at least one being sulphur; R1 is hydrogen, hydroxy, (C1 -C6)alkyl, (C2 -C | 08/21/2001 |
| 6255299 | Opthalmic gel composition and method of treating eye infections An ophthalmic gel composition for human and veterinary use comprising 0.5-4% w/v of fusidic acid suspended in an aqueous vehicle containing 0.2-2% w/v of a polyanionic polymer.... | 07/03/2001 |
| 6207656 | Vitamin D analogues and their neuronal effects The present invention is directed, inter alia, to methods of utilizing low calcemic vitamin D analogues. Particularly, the present invention is directed to using low calcemic vitamin D analogues to treat neurodegenerative diseases and disorders, to facili... | 03/27/2001 |
| 6197982 | Vitamin D analogues The present invention relates to compounds of formula (I), in which formula X is hydrogen or hydroxy; R1 and R2, which may be the same or different, stand for hydrogen or a C1 -C3 alkyl radical; or R1... | 03/06/2001 |
| 6177418 | Tetracyclic triterpenes as cholesterol-lowering and anti-atherosclerosis agents The invention is directed to compounds, compositions and method of preparation of compounds of formulae I and II: ##STR1## wherein X, Q1, Q2, R1 and R2 are as defined by the specification. The compounds are disc... | 01/23/2001 |
| 6121297 | Cyanoguanidines as cell proliferation inhibitors The present invention relates to hitherto unknown compounds of formula (I) or their tautomeric forms, the attachment to the pyridine ring being in the 3- or 4-position, in which formula R1 stands for one or more substituents which can be the sa... | 09/19/2000 |
| 5994332 | Vitamin D analogues The present invention relates to compounds of formula (I) in which formula X is hydrogen or hydroxy; R1 and R2 stand for methyl or ethyl, or, when taken together with the carbon atom bearing the group X, can form a C3 -C | 11/30/1999 |
| 5945433 | Quinoline derivatives containing a diol as leukotriene antagonists The present invention relates to hitherto unknown compounds of formula (I) in which R1 is hydrogen or halogen, preferably fluorine or chlorine, and m is 0, 1 or 2. The present compounds are of value in the human and veterinary practice as leuko... | 08/31/1999 |
| 5763426 | Crystalline form of a vitamin D analogue The present invention relates to calcipotriol hydrate--a new crystalline form of calcipotriol--with superior technical properties and with superior stability.... | 06/09/1998 |
| 5696140 | N-cyano-N'-pyridylguanidines as serotonin antagonists The present invention relates to hitherto unknown compounds of formula or their tautomeric forms, the attachment to the pyridine ring being in the 3- or 4-position, in which R', R" are the same or different and stand for hydrogen, halogen, or trifluoromet... | 12/09/1997 |
| 5554599 | 22-thio vitamin D derivatives The present invention relates to compounds of the following formula ##STR1## in which Y is sulfur, S(O), or S(O)2 ; R stands for C1 -C3 alkyl, or can form a C3 -C8 carbocyclic ring. Q is a C1 | 09/10/1996 |
| 5447924 | Vitamin D analogues Vitamin D analogues of the formula: ##STR1## wherein X is hydrogen or hydroxy; R1 and R2 are each hydrogen or C1 -C6 hydrocarbyl or R1 and R2 together with the starred carbon form a C | 09/05/1995 |
| 5292727 | Use of the treatment of acne The present invention relates to the use of certain vitamin D analogues in the preparation of a pharmaceutical preparation for the treatment of acne. The preparation contains a vitamin D analogue (calcipotriol) which has only moderate activity on the calc... | 03/08/1994 |
| 5244664 | Topical preparation for treatment of alopecia This invention relates to pharmaceutical compositions for treatment of alopecia comprising a compound of formula, in the form of the free base or acid addition salts thereof, in association with a pharmaceutical carrier adapted for topical application to ... | 09/14/1993 |
| 5234932 | Substituted quinolines and leucotriene antagonism treatment therewith The present invention relates to hitherto unknown compounds of formula, in which m and n stand for an integer from 0-5, p stands for 0 or 1, and q stands for an integer from 0-4, R1 and R2 are the same or different and stand for hydr... | 08/10/1993 |
| 5157039 | 2-quinolinyl methoxy compounds, medical uses and intermediates therefor The present invention relates to compounds of formula ##STR1## in which formula I X stands for O, S, ##STR2## R1 and R2 which can be the same or different stand for hydrogen, straight or branched, saturated or unsaturated, ... | 10/20/1992 |
| 5130304 | N-heterocyclic propylidene-1,1-bisphosphonic acids, their production and a pharmaceutical composition The present invention relates to compounds of formula in which R1 -R8 can be the same or different and stand for hydrogen or a straight or branched aliphatic C1 -C10 hydrocarbon radical. In addition, R3 | 07/14/1992 |
| 5110819 | Substituted quinolines and medicinal use thereof The present invention relates to hitherto unknown compounds of formula, in which formula R1 stands for hydrogen, straight or branched, saturated or unsaturated, unsubstituted or substituted C1 --C8 --alkyl, aryl or for ar-... | 05/05/1992 |
| 5109009 | Quinoline and pyridine compounds and inhibition of 5-lipoxygenases therewith The present invention relates to compounds of formula ##STR1## in which formula I X stands for O, S, ##STR2## R1 and R2 which can be the same or different stand for hydrogen, straight or branched, saturated or unsaturated, ... | 04/28/1992 |
| 4882325 | Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-amino-phenylacetamido)penicillanate napsylate and method of using the same Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(D--amino--phenylacetamido)penicillanate napsylate. The product may be prepared by reacting 1,1-dioxopenicillanoyloxymethyl 6-(D--amino--phenylacetamido)penicillanate or a salt ther... | 11/21/1989 |
